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Within the European Network for the Rapid Identiﬁcation of Anaerobes (ENRIA) project eight clinical
isolates of Fenollaria massiliensis were encountered. In this study a more extensive description of this
species is given and the MALDI-TOF MS database is optimized for its identiﬁcation.
F. massiliensis is an anaerobic Gram positive rod with the tendency to decolorize quickly. It is mostly
encountered in clinical samples from the groin region.
Less common and non-valid species are not represented in the MALDI-TOF MS database. Therefore,
F. massiliensis can only be identiﬁed by laboratories performing 16S rDNA gene sequencing. The addition
of less common and non-valid species to the database will give insight in their clinical relevance.
© 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Due to the introduction of Matrix Assisted Laser Desorption
Ionization e Time of Flight Mass Spectrometry (MALDI-TOF MS) in
diagnostic laboratories, species which previously remained un-
identiﬁed can now be identiﬁed easily [14,16]. Until now, it was
only possible to identify relatively unknown species by 16S rDNA
gene sequencing, which is expensive and time consuming in
comparison to MALDI-TOF MS [10].
However, identiﬁcation can only be performed if the database
accompanying MALDI-TOF MS systems contain a sufﬁcient number
of high quality Main Spectral Proﬁles (MSPs) representing species
encountered in human clinical specimens [10].
The goal of the European Network for the Rapid Identiﬁcation of
Anaerobes (ENRIA) project is to optimize the MALDI-TOF MS
database for the identiﬁcation of anaerobes. Within this project
anaerobic clinical isolates were encountered which could, University Medical Center
zeplein 1, 9713 GZ Groningen,
Ltd. This is an open access article upreviously not be identiﬁed using MALDI-TOF MS, for example
Fenollaria massiliensis.
Due to the optimization of the MALDI-TOF MS database we
encountered eight clinical isolates of F. massiliensis. The initial
description of this species was based on one clinical isolate,
rendering its clinical relevance unknown [7].
In this study a more extensive description of the biochemical
features and an insight in the clinical relevance of F. massiliensis is
given. Furthermore, the MALDI-TOF MS database is optimized for
the identiﬁcation of this species.
2. Material and methods
2.1. Bacterial strains
Eight strains of F. massiliensis were isolated from clinical sam-
ples, six strains at the Centre Hospitalier Universitaire de Mont-
pellier, France and two strains at the University Medical Center
Groningen, The Netherlands. The strains originated from bone tis-
sue, a perianal abscess, a vulva abscess, a cutaneous ﬂap infection, a
cutaneous ﬁstula, a post-operative scar and two strains from sperm
samples. Furthermore, the type strain F. massiliensis CSUR P127T
was included in all tests.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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products BV, Groningen, The Netherlands) supplemented with
hemin (5mg/L) and vitamin K (10mg/L), and incubated in anaer-
obic conditions (80% N2, 10% H2, and 10% CO2) at 35 C for 48 h.
2.2. Biochemical features
The special potency discs; vancomycin (5 mg), kanamycin
(1000 mg), colistin (10 mg) and bile, were used for preliminary
identiﬁcation of anaerobic bacteria, according to the wadsworth
manual [4].
Biochemical features were assessed using the rapid ID 32A
(bioMerieux S.A., Marcy l’Etoile, France), according to the recom-
mendations of the manufacturer.
2.3. Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using
Etests® (bioMerieux S.A., Marcy l’Etoile, France). Susceptibility to
amoxicillin, amoxicillin-clavulanic acid, clindamycin, metronida-
zole, meropenem and tetracycline was assessed. All Etests® were
incubated for 48 h in an anaerobic environment on BBA agar.Table 1
Clinical information of the F. massiliensis strains.
Strain Gender (age) Origin
UMCG-9195 Male (48) bone (tibia) tissue from a patient with chronic osteo
UMCG-6509 Female (33) Pus perianal abscess
FR5551 Female (33) vulva abscess
FR5612 Male (35) sperm
FR6112 Male (35) sperm
FR6108 Male (50) Infection on a cutaneous ﬂap (ischium level)
FR6144 Male (66) Suppuration of a cutaneous ﬁstula after curing ingui
FR0557 unknown post-operative scarMinimal Inhibitory Concentrations (MICs) were interpreted ac-
cording to the breakpoints provided by EUCAST (http://www.
eucast.org/), except for tetracycline. Since EUCAST gives no break-
points for tetracycline, the CLSI guidelines were used. Beta-
lactamase activity was tested using BBL ceﬁnase discs (Becton,
Dickinson and Company, US).
2.4. DNA isolation, 16S rDNA gene sequencing and phylogenetic
analysis
DNA of FR0557 and UMCG-9195 was extracted as described by
Boom et al. [1]. 16S rDNA gene sequencing of strains was performed
at the UMCG using universal primers. Of strain FR0557 the whole
16S rDNA gene was sequenced [9] and of strain UMCG-9195 only
the ﬁrst 500bp [2]. The identity of the strains was conﬁrmed using
BLASTn, hereby comparing the obtained 16S rDNA sequences with
reference sequences available in GenBank (https://blast.ncbi.nlm.
nih.gov/Blast.cgi). The threshold value for a reliable species iden-
tiﬁcation was set at >98,7% [12].
Using MEGA 7 [5], a phylogenetic tree was constructed. All
sequence fragments were aligned and a ﬁlter was set to ensure
equal length. Branching was determined using the neighbor-Other pathogens
Aerobic Anaerobic
myelitis Corynebacterium aurimucosum F. massiliensis
Dermabacter hominis Actinomyces turicensis
Staphylococcus simulans Actinotignum schaalii
Streptococcus mitis group Anaerococcus lactolyticus
Peptoniphilus harei
Aerobic Gram positive mixture F. massiliensis





Gardnerella vaginalis F. massiliensis
Staphylococcus caprae Peptoniphilus spp.
Porphyromonas asaccharolyticus
Cutibacterium avidum



















Gram positive anaerobic cocci
Fig. 1. Gram stain of F. massiliensis strain UMCG-9195.
Table 2
Biochemical features of F. massiliensis determined by rapid ID 32A.
F. massiliensis
Pagnier et al. [6]
CSUR P127T ENRIA isolates
URE e e e
ADH e þ þ
aGAL e e e
bGAL e e e
bGP e e e
aGLU e e e
bGLU e e e
aARA e e e
bGUR e e e
bNAG e þ v
MNE e e e
RAF e e e
GDC e e e
aFUC e e e
NIT e e e
IND þ þ v
PAL e e e
ArgA þ þ þ
ProA e e e
LGA e þ þ
PheA e þ þ
LeuA þ þ þ
PyrA þ þ þ
TyrA þ þ þ
AlaA e þ þ
GlyA þ þ þ
HisA þ þ þ
GGA e þ þ
SerA þ þ þ
v: variable, URE: urease, ADH: arginine dihydrolase, aGAL: a-galactosidase, bGAL: b-
galactosidase, bGP: b-galactosidase phosphate, aGLU: a-glucosidase, bGLU: b-
glucosidase, aARA: a-arabinosidase, bGUR: b-glucuronidase, bNAG: N-acetyl-b-
glucosaminidase, MNE: mannose fermentation, RAF: rafﬁnose fermentation, GDC:
glutamic acid decarboxylase, aFUC: a-fucosidase, NIT: nitrate reduction, IND: indole
production, PAL: alkaline phosphatase, ArgA: arganine arylamidase, ProA: Proline
arylamidase, LGA: leucyl glycine arylamidase, PheA: Phenylalanine arylamidase,
LeuA: leucine arylamidase, PyrA: pyroglutamic acid arylamidase, TyrA: tyrosine
arylamidase, AlaA: alanine arylamidase, GlyA: glycine arylamidase, HisA: histidine
arylamidase, GGA: glutamyl glutamic acid arylamidase, SerA: serine arylamidase.
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FR0557, the type strains of F. massiliensis 9401234T (NR_133038)
and F. timonensis GD5T (LN 881613), and anaerobic species
belonging to the same family were included.
2.5. MALDI-TOF MS
2.5.1. MSP creation
A full extraction of the strains was performed as described
previously by Veloo et al. [15]. Brieﬂy, an ethanol suspension was
made by dissolving a 1 ml loop full of bacteria in 300 ml sterile
distilled water. After obtaining a homogeneous suspension 900 ml
of pure ethanol was added. The suspension was centrifuged for
2min at 13.000 g and the supernatant was removed. This step was
repeated and the supernatant was carefully removed by pipetting.
The pellet was dissolved in 30 ml of 70% formic acid. An equal
amount of acetonitrile was added and the suspension was centri-
fuged for 2min at 13.000 g. 1 ml of the supernatant was spotted
twelve times on a steel 96 wells target and dried at ambient tem-
perature. Immediately after drying 1 ml of a-cyano-4-hydroxycin-
namic acid (HCCA) matrix was added and left to dry at ambient
temperature.
Each spot wasmeasured 3 times using amicroﬂex LT/SHMALDI-
TOF MS system (Bruker daltonik GmbH, Bremen, Germany),
resulting in 36 spectra. Prior to the measurement the MALDI-TOF
MS system was calibrated using the Bacterial test standard (BTS,
Bruker daltonik GmbH, Bremen, Germany).
Using FlexAnalysis 3.4 a smoothing and baseline subtraction
was performed on the spectra in accordance with FlexAnalysis
method MBT_standard. The spectra were manually evaluated. All
ﬂatliners and remarkably different spectra were discarded from the
dataset. The remaining spectra were checked for peak shifts, which
should be less than 500 ppm. All spectra that exceeded this value
were discarded from the data set as well. AMSPwas calculated of at
least 20 spectra using MBT Compass Explorer 4.1.
A dendrogram was created of the in house made F. massiliensis
MSPs and MSPs of anaerobic species, which were also used to
calculate the phylogenetic tree, using MBT Compass Explorer.
Furthermore, two MSPs for F. timonensis, available at the website
http://www.mediterranee-infection.com/article.php?
larub¼280&titre¼urms-database from Durand et al. [3], were
downloaded and added to the dendrogram.
2.5.2. Strain identiﬁcation
The MSPs of strains FR0557 and UMCG-9195 were used to
identify the six other F. massiliensis strains. The MALDI-TOF MS
measurements were performed as previously described by Veloo
et al. [13]. After 48 h of subculturing on BBA, each strainwas spotted
in duplicate on a stainless steel target plate.1 ml of HCCAmatrix wasTable 3
MIC values for different antibiotics.
Strain MIC (mg/L)
AC XL CM MZ MP TE
CSUR P127T <0.016 <0.016 1.0 0.094 <0.002 16
UMCG-9195 <0.016 <0.016 1.0 <0.016 <0.002 0.125
UMCG-6509 0.023 0.016 0.38 0.094 <0.002 0.5
FR5551 0.016 0.016 0.5 0.047 <0.002 0.25
FR5612 <0.016 <0.016 0.032 0.016 <0002 0.032
FR6112 <0.016 <0.016 16 0.047 <0.002 8.0
FR6108 0.032 0.032 0.5 0.125 0.004 0.75
FR6144 0.016 0.023 >256 0.19 <0.002 0.25
FR0557 <0.016 0.016 1.5 0.19 0.004 0.38
AC: Amoxicillin, XL: Amoxicillin clavulanic acid, CM: Clindamycin, MZ: Metroni-
dazole, MP: Meropenem, TE: Tetracycline.
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The MALDI-TOF MS results were interpreted as recommended
by the manufacturer (Bruker daltonik GmbH, Bremen, Germany).
Log scores 2.0 were considered as an identiﬁcation with high
conﬁdence, log scores of 1.7e2.0 were considered as an identiﬁ-
cation with low conﬁdence. Log scores <1.7 were considered as no
reliable identiﬁcation.3. Results
3.1. Bacterial strains
All strains were isolated from mixed infections with either
anaerobic bacteria or both aerobic and anaerobic bacteria (Table 1).
In three clinical samples solely anaerobic isolates were encoun-
tered. Furthermore, from each clinical sample Gram positive
anaerobic cocci (GPAC) were isolated and two contained besides
F. massiliensis only GPAC.3.2. Biochemical features
All F. massiliensis strains showed good growth after 48 h of in-
cubation on BBA. Colonies were small, circular, bright greyish, non-
hemolytic with a diameter of 0.5e1.5mm. All strains were catalase
negative. The Gram stain showed pleomorphic Gram positive rods
with round bodies on ﬁlaments (Fig. 1). The bacterial cells show a
tendency to decolorize easily. All strains were sensitive to vanco-
mycin, kanamycin and bile but resistant to colistin using the special
potency discs.
Using rapid ID 32A all strains showed positive reactions for
arginine dihydrolase, arginine arylamidase, leucyl glycineFig. 2. Dendrogram of all F. massiliensis sarylamidase, phenylalanine arylamidase, leucine arylamidase,
pyroglutamic acid arylamidase, tyrosine arylamidase, alanine ary-
lamidase, glycine arylamidase, histidine arylamidase, glytamyl
glutamic acid arylamidase and serine arylamidase. Negative re-
actions were observed for urease, a-galactosidase, b-galactosidase,
b-galactosidase phosphate, a-glucosidase, b-glucosidase, a-arabi-
nosidase, b-glucuronidase, mannose, rafﬁnose, glutamic acid
decarboxylase, a-fucosidase, nitrate, alkaline phosphatase and
proline arylamidase. Variable results were observed for N-acetyl-b-
glucosaminidase and indole production. The type strain CSUR
P127T showed similar results in the rapid ID 32A (Table 2).3.3. Antimicrobial susceptibility
All strains produced no beta-lactamase and were susceptible for
amoxicillin, amoxicillin/clavulanic acid, metronidazole and mer-
openem. Two of the eight clinical strains were resistant to clinda-
mycin, MICs of 16mg/L and >256mg/L, and one strain was
intermediate to tetracycline, MIC of 8mg/L. The type strain CSUR
P127T was susceptible to all tested antibiotics, except for tetracy-
cline, for which a MIC of 16mg/L was observed (Table 3).3.4. MALDI-TOF MS
No reliable identiﬁcationwas obtained using the MALDI-TOFMS
with the Bruker version 6 (6903 MSPs) database. After the addition
of in house made F. massiliensis MSPs of strains UMCG-9195 and
FR0557 to the database, all strains, including the type strain, could
be identiﬁed with a high conﬁdence log score. Comparing the ob-
tained spectra of all F. massiliensis strains to theMSP of F. timonensis,
yielded a log score <1.7.trains and related anaerobic species.
Fig. 3. Phylogenetic tree showing the relationship of F. massiliensis with related anaerobic species. Only bootstrap values of >90% are shown.
K.E. Boiten et al. / Anaerobe 54 (2018) 240e245244The obtained dendrogram is shown in Fig. 2. The in house
created MSPs of F. massiliensis cluster closely together and show a
close relation to F. timonensis. A clear difference was seen with the
Fenollaria strains and other genera.3.5. 16S rDNA sequencing
Strains FR0557 and UMCG-9195 each had a sequence similarity
of 99% with F. massiliensis.
The obtained phylogenetic tree is shown in Fig. 3. Strain FR0557
clusters closely together with the type strain of F. massiliensis and
shows a close relationship with the type strain of F. timonensis.4. Discussion
In this study, the biochemical characteristics and clinical rele-
vance of F. massiliensis are described.
F. massiliensis is a relatively unknown anaerobic bacterium,
originating from an osteoarticular sample from a patient in France
[7] and was classiﬁed as being a Gram negative rod. The genus
Fenollaria consists out of two species: F. massiliensis and
F. timonensis [3]. Due to the introduction of molecular techniques
more and more new species are described. It is of the outmost
importance that new species are validated by the International
Journal of Systemic and Evolutionary Microbiology (IJSEM) and
accepted by the International Committee on Systemics of Pro-
karyotes (ICSP, http://www.the-icsp.org/). F. massiliensis was
recently published in IJSEM as a valid species [6]. However,
F. timonensis is still a non-valid species. Non-valid species are not
represented in the MALDI-TOF MS database and are therefore notidentiﬁed by laboratories not performing 16S rDNA gene
sequencing. We showed that, when using an improved database,
F. massiliensis can easily be identiﬁed using MALDI-TOF MS. The
addition of less common and non-valid species facilitates the
assessment of the clinical relevance of such species.
We noticed that the ﬁrst cultures of F. massiliensis yielded Gram
positive stained cells which after several sub cultures stained Gram
negative.
Analysis of the genome (NZ_CALI00000000) yielded ﬁve genes
for a Gram positive cell wall (all belonging to the family of glyco-
syltransferase) and only one gene for a Gram negative cell wall
(data not shown). Glycosyltransferases play an important role in
the biosynthesis of wall teichoid acids, which are an important part
of the peptidoglycan layer of Gram positive bacteria [11]. The
wadsworth manual [4] mentions that Gram positive organisms are
most likely to be sensitive to the special potency disc vancomycin,
whereas Gram negative organisms are most likely to be resistant.
Since several Gram positive anaerobic bacteria have the tendency
to decolorize easily in a Gram stain, we suspect that this is also the
case with F. massiliensis and was therefore mistaken to be a Gram
negative species.
The obtained biochemical features of the type strain of
F. massiliensis were similar as the ones obtained for the clinical
isolates. However, we observed positive reactions for arginine
dihydrolase, N-acetyl-b-glucosaminidase, leucyl glycine arylami-
dase, phenylalanine arylamidase, alanine arylamidase and glutamyl
glutamic acid arylamidase, which is in contrast with the
biochemical features described by Pagnier et al. [7]. The type strain
of F. massiliensis was the only strain resistant to tetracycline.
Six F. massiliensis strains were isolated from clinical samples
K.E. Boiten et al. / Anaerobe 54 (2018) 240e245 245originating from the groin region. It is interesting to notice that
Sabat et al. [8] recently encountered F. massiliensis in urine samples
using direct targeted next-generation sequencing. In this study,
four out of sixty urine samples were shown to contain DNA of
F. massiliensis, ranging from 15.6% till 0.4% of the total bacterial
DNA. Taking also our ﬁndings into the account, this might indicate
that the groin region is the commensal habitat of F. massiliensis.
In summary, F. massiliensis is an anaerobic Gram positive rod
present in the groin region. This study shows the importance of
adding MSPs of less common and non-valid species to the MALDI-
TOF MS database.
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